Jul 9, 2026 07:00AM
Jul 9, 2026 07:00AM
Jul 1, 2026 07:02AM
Jul 1, 2026 07:00AM
Jun 25, 2026 07:00AM
Jun 25, 2026 07:00AM
Jun 23, 2026 08:03AM INmune Bio gets MHRA alignment for 2026 UK drug application
Jun 23, 2026 08:00AM
Jun 2, 2026 08:01AM
Jun 2, 2026 08:00AM
Jun 2, 2026 08:00AM
Jun 2, 2026 08:00AM
May 15, 2026 08:00AM
May 15, 2026 08:00AM INmune Bio publishes Phase 2 Alzheimer's trial results in peer-reviewed journal
May 15, 2026 08:00AM
May 14, 2026 08:00AM
May 14, 2026 08:00AM
May 14, 2026 08:00AM
May 14, 2026 08:00AM
May 13, 2026 08:00AM
May 7, 2026 04:00PM INmune Bio Inc. Announces First Quarter 2026 Results and Provides Business Update
May 5, 2026 04:00PM
May 5, 2026 04:00PM
Apr 30, 2026 08:00AM
Apr 16, 2026 11:42AM
Apr 16, 2026 08:00AM
Apr 16, 2026 08:00AM
Apr 16, 2026 08:00AM INmune Bio Inc. Announces New Preclinical Data at AACR 2026 Demonstrating INB03 (XPro1595) Overcomes Resistance and Reduces Metastases in HER2-Positive Breast Cancer Models
Mar 30, 2026 04:00PM
Mar 30, 2026 04:00PM
Mar 24, 2026 08:00AM
Mar 19, 2026 08:00AM
Feb 23, 2026 09:25AM
Feb 19, 2026 12:16PM
Feb 19, 2026 12:15PM INmune Bio Announces Upcoming Webinar to Present New Clinical Data on CORDStrom™ for RDEB
Feb 12, 2026 07:01AM
Feb 12, 2026 07:00AM
Feb 10, 2026 08:04AM
Feb 10, 2026 08:00AM
Jan 27, 2026 09:25AM
Jan 27, 2026 09:25AM
Dec 5, 2025 07:00AM Peer Reviewed Study Highlights Therapeutic Potential Around Application of Stromal Cell Therapies Such as INmune Bio’s CORDStrom™ Platform
Dec 1, 2025 08:03AM
Dec 1, 2025 08:00AM
Dec 1, 2025 08:00AM
Dec 1, 2025 08:00AM
Nov 18, 2025 08:00AM
Oct 30, 2025 04:05PM
Oct 23, 2025 07:00AM INmune Bio Inc. to Report Third Quarter 2025 Financial Results and Provide a Corporate Update on Thursday, October 30, 2025
Oct 14, 2025 07:00AM

325,536 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All